247 related articles for article (PubMed ID: 11318363)
21. Additional local therapy with primary re-excision or radiation therapy improves survival and local control after incomplete or close surgical excision of mast cell tumors in dogs.
Kry KL; Boston SE
Vet Surg; 2014 Feb; 43(2):182-9. PubMed ID: 24392683
[TBL] [Abstract][Full Text] [Related]
22. Recurrence rate, clinical outcome, and cellular proliferation indices as prognostic indicators after incomplete surgical excision of cutaneous grade II mast cell tumors: 28 dogs (1994-2002).
Séguin B; Besancon MF; McCallan JL; Dewe LL; Tenwolde MC; Wong EK; Kent MS
J Vet Intern Med; 2006; 20(4):933-40. PubMed ID: 16955819
[TBL] [Abstract][Full Text] [Related]
23. The prognostic value of lymph node metastasis with grade 2 MCTs in dogs: 55 cases (2001-2010).
Baginski H; Davis G; Bastian RP
J Am Anim Hosp Assoc; 2014; 50(2):89-95. PubMed ID: 24446400
[TBL] [Abstract][Full Text] [Related]
24. Iridium-192 interstitial brachytherapy as adjunctive treatment for canine cutaneous mast cell tumors.
Northrup NC; Roberts RE; Harrell TW; Allen KL; Howerth EW; Gieger TL
J Am Anim Hosp Assoc; 2004; 40(4):309-15. PubMed ID: 15238561
[TBL] [Abstract][Full Text] [Related]
25. Deionised water as an adjunct to surgery for the treatment of canine cutaneous mast cell tumours.
Jaffe MH; Hosgood G; Kerwin SC; Hedlund CS; Taylor HW
J Small Anim Pract; 2000 Jan; 41(1):7-11. PubMed ID: 10713976
[TBL] [Abstract][Full Text] [Related]
26. Soft tissue sarcomas and mast cell tumours in dogs; clinical behaviour and response to surgery.
Baker-Gabb M; Hunt GB; France MP
Aust Vet J; 2003 Dec; 81(12):732-8. PubMed ID: 15080482
[TBL] [Abstract][Full Text] [Related]
27. Impact of tumour depth, tumour location and multiple synchronous masses on the prognosis of canine cutaneous mast cell tumours.
Kiupel M; Webster JD; Miller RA; Kaneene JB
J Vet Med A Physiol Pathol Clin Med; 2005 Aug; 52(6):280-6. PubMed ID: 16050909
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical detection of proliferating cell nuclear antigen and Ki-67 in mast cell tumors from dogs.
Abadie JJ; Amardeilh MA; Delverdier ME
J Am Vet Med Assoc; 1999 Dec; 215(11):1629-34. PubMed ID: 14567425
[TBL] [Abstract][Full Text] [Related]
29. Prognostic factors for surgical treatment of soft-tissue sarcomas in dogs: 75 cases (1986-1996).
Kuntz CA; Dernell WS; Powers BE; Devitt C; Straw RC; Withrow SJ
J Am Vet Med Assoc; 1997 Nov; 211(9):1147-51. PubMed ID: 9364229
[TBL] [Abstract][Full Text] [Related]
30. Radiotherapy of incompletely resected, moderately differentiated mast cell tumors in the dog: 37 cases (1989-1993).
Frimberger AE; Moore AS; LaRue SM; Gliatto JM; Bengtson AE
J Am Anim Hosp Assoc; 1997; 33(4):320-4. PubMed ID: 9204467
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical and clinical evaluation of p53 in canine cutaneous mast cell tumors.
Jaffe MH; Hosgood G; Taylor HW; Kerwin SC; Hedlund CS; Lopez MK; Davidson JR; Miller DM; Paranjpe M
Vet Pathol; 2000 Jan; 37(1):40-6. PubMed ID: 10643979
[TBL] [Abstract][Full Text] [Related]
32. Mast cell tumour destruction in dogs by hypotonic solution.
Grier RL; Di Guardo G; Myers R; Merkley DF
J Small Anim Pract; 1995 Sep; 36(9):385-8. PubMed ID: 8583766
[TBL] [Abstract][Full Text] [Related]
33. Long-term postsurgical outcomes of mast cell tumors resected with a margin proportional to the tumor diameter in 23 dogs.
Itoh T; Kojimoto A; Uchida K; Chambers J; Shii H
J Vet Med Sci; 2021 Feb; 83(2):230-233. PubMed ID: 33342962
[TBL] [Abstract][Full Text] [Related]
34. Hypotonic water as adjuvant therapy for incompletely resected canine mast cell tumors: a randomized, double-blind, placebo-controlled study.
Brocks BA; Neyens IJ; Teske E; Kirpensteijn J
Vet Surg; 2008 Jul; 37(5):472-8. PubMed ID: 18986315
[TBL] [Abstract][Full Text] [Related]
35. Comparison of lateral surgical margins of up to two centimeters with margins of three centimeters for achieving tumor-free histologic margins following excision of grade I or II cutaneous mast cell tumors in dogs.
Chu ML; Hayes GM; Henry JG; Oblak ML
J Am Vet Med Assoc; 2020 Mar; 256(5):567-572. PubMed ID: 32068517
[TBL] [Abstract][Full Text] [Related]
36. Use of a reverse saphenous skin flap for the excision of a grade II mast cell tumor on the hind limb of a dog.
Brière C
Can Vet J; 2002 Aug; 43(8):620-2. PubMed ID: 12170840
[TBL] [Abstract][Full Text] [Related]
37. Prednisone and vinblastine chemotherapy for canine mast cell tumor--41 cases (1992-1997).
Thamm DH; Mauldin EA; Vail DM
J Vet Intern Med; 1999; 13(5):491-7. PubMed ID: 10499735
[TBL] [Abstract][Full Text] [Related]
38. Cutaneous mast cell tumors in cats: 32 cases (1991-1994).
Molander-McCrary H; Henry CJ; Potter K; Tyler JW; Buss MS
J Am Anim Hosp Assoc; 1998; 34(4):281-4. PubMed ID: 9657159
[TBL] [Abstract][Full Text] [Related]
39. Intranasal mast cell tumor in the dog: A case series.
Khoo A; Lane A; Wyatt K
Can Vet J; 2017 Aug; 58(8):851-854. PubMed ID: 28761193
[TBL] [Abstract][Full Text] [Related]
40. Radiation therapy for canine mast cell tumors.
Mayer MN
Can Vet J; 2006 Mar; 47(3):263-5. PubMed ID: 16604985
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
